US2017319743A1PendingUtilityA1
Alimentary Protein-Based Scaffolds (APS) for Wound Healing, Regenerative Medicine and Drug Discovery
Est. expiryFeb 14, 2027(~0.5 yrs left)· nominal 20-yr term from priority
A61P 17/02A61L 15/32A61L 15/40A61L 27/3637A61L 27/227C12N 2533/50A61L 27/3691C12N 5/0068A61L 27/26A61L 27/60A61L 27/3804A61L 27/24D01F 4/00A61L 27/22A61L 27/38D01D 5/0007A61K 36/48
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides engineered biomaterials derived from plant products. The engineered biomaterials are useful for biomedical applications. The engineered biomaterials are able to support the growth of animal calls.
Claims
exact text as granted — not AI-modified1 - 30 . (canceled)
31 . A method of treating a wound in a subject, the method comprising contacting an electroprocessed composition comprising fibers of a plant product-derived biomaterial and a synthetic polymer to a subject in need thereof.
32 . The method of claim 31 , wherein said electroprocessed is electrospun.
33 . The method of claim 31 , wherein said plant product is from a plant selected from the group consisting of corn, wheat, potato, sorghums, tapioca, rice, arrow root, sago, soybean, pea, sunflower, peanut, gelatin, and any combination thereof.
34 . The method of claim 31 , wherein said plant product is soy protein isolate.
35 . The method of claim 31 , wherein said plant product is corn zein.
36 . The method of claim 31 , wherein said composition is capable of supporting cell growth.
37 . The method of claim 31 , wherein said composition is capable of supporting the maintenance of a differentiation state of a cell.
38 . The method of claim 31 , further comprising a cell.
39 . The method of claim 38 , wherein said cell is genetically modified.
40 . The method of claim 31 further comprising a material selected from the group consisting of fibronectin, laminin, collagen, glycoprotein, thrombospondin, elastin, fibrillin, mucopolysaccharide, glycolipid, heparin sulfate, chondroitin sulfate, keratin sulfate, glycosaminoglycan, hyaluronic acid, proteoglycan, vitronectin, poly-D-lysine, polysaccharide, and any combination thereof.
41 . The method of claim 31 further comprising an adhesive.
42 . The method of claim 31 , wherein said synthetic material is selected from the group consisting of poly(epsilon-caprolactone) (PCL), poly(lactic acid) (PLA), poly(glycolic acid) (PGA), copolymers poly (lactide-co-glycolide) (PLGA), polyaniline, poly(ethylene oxide) (PEO), and any combination thereof.Join the waitlist — get patent alerts
Track US2017319743A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.